TransMedics (TMDX) Payables (2018 - 2026)

TransMedics has reported Payables for 9 years, with the latest figure at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 5.25% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (up 5.25% YoY), and the FY2025 full-year result was $10.4 million, up 0.56% from the prior year.
• Payables for Q1 2026 stood at $11.2 million, up from $10.4 million in the prior quarter.
• The five-year high for Payables was $13.1 million in Q3 2024, with the low at $2.9 million in Q1 2022.
• Average Payables over 5 years is $8.9 million, with a median of $10.3 million recorded in 2024.
• Year-over-year, Payables slumped 49.77% in 2022 and jumped 316.75% in 2023.
• Tracing TMDX's Payables over 5 years: stood at $3.3 million in 2022, then jumped by 280.63% to $12.7 million in 2023, then decreased by 19.07% to $10.3 million in 2024, then increased by 0.56% to $10.4 million in 2025, then gained by 7.74% to $11.2 million in 2026.
• The last three Payables figures came in at $11.2 million (Q1 2026), $10.4 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.

Peer Comparison